IT9022513A0 - Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. - Google Patents

Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Info

Publication number
IT9022513A0
IT9022513A0 IT9022513A IT2251390A IT9022513A0 IT 9022513 A0 IT9022513 A0 IT 9022513A0 IT 9022513 A IT9022513 A IT 9022513A IT 2251390 A IT2251390 A IT 2251390A IT 9022513 A0 IT9022513 A0 IT 9022513A0
Authority
IT
Italy
Prior art keywords
heptastigmine
therapy
cerebral stroke
cerebral
stroke
Prior art date
Application number
IT9022513A
Other languages
English (en)
Other versions
IT9022513A1 (it
IT1246050B (it
Inventor
Bono Rinaldo Del
Bruno Pietro Imbimbo
Original Assignee
Mediolanum Farmaceutici Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl
Publication of IT9022513A0 publication Critical patent/IT9022513A0/it
Priority to IT02251390A priority Critical patent/IT1246050B/it
Priority to EP91121676A priority patent/EP0492383B1/en
Priority to DE69118847T priority patent/DE69118847T2/de
Priority to AT91121676T priority patent/ATE136776T1/de
Priority to ES91121676T priority patent/ES2085411T3/es
Priority to IE446391A priority patent/IE914463A1/en
Priority to JP3354447A priority patent/JPH04308529A/ja
Priority to KR1019910023605A priority patent/KR920011482A/ko
Priority to CA002058228A priority patent/CA2058228A1/en
Publication of IT9022513A1 publication Critical patent/IT9022513A1/it
Application granted granted Critical
Publication of IT1246050B publication Critical patent/IT1246050B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
IT02251390A 1990-12-21 1990-12-21 Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. IT1246050B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT02251390A IT1246050B (it) 1990-12-21 1990-12-21 Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
ES91121676T ES2085411T3 (es) 1990-12-21 1991-12-18 Uso de heptastigmina en la terapia de ictus cerebral.
DE69118847T DE69118847T2 (de) 1990-12-21 1991-12-18 Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
AT91121676T ATE136776T1 (de) 1990-12-21 1991-12-18 Verwendung von heptastigmin zur behandlung der zerebralen ictus
EP91121676A EP0492383B1 (en) 1990-12-21 1991-12-18 Use of heptastigmine in the therapy of cerebral ictus
IE446391A IE914463A1 (en) 1990-12-21 1991-12-19 Use of heptastigmine in the therapy of cerebral ictus
JP3354447A JPH04308529A (ja) 1990-12-21 1991-12-20 脳発作の治療におけるヘプタスチグミンの使用
KR1019910023605A KR920011482A (ko) 1990-12-21 1991-12-20 뇌 발작을 치료하는데 있어서의 헵타스티그민의 용도
CA002058228A CA2058228A1 (en) 1990-12-21 1991-12-20 Use of heptastigmine in the therapy of cerebral ictus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02251390A IT1246050B (it) 1990-12-21 1990-12-21 Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Publications (3)

Publication Number Publication Date
IT9022513A0 true IT9022513A0 (it) 1990-12-21
IT9022513A1 IT9022513A1 (it) 1992-06-21
IT1246050B IT1246050B (it) 1994-11-07

Family

ID=11197279

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02251390A IT1246050B (it) 1990-12-21 1990-12-21 Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Country Status (9)

Country Link
EP (1) EP0492383B1 (it)
JP (1) JPH04308529A (it)
KR (1) KR920011482A (it)
AT (1) ATE136776T1 (it)
CA (1) CA2058228A1 (it)
DE (1) DE69118847T2 (it)
ES (1) ES2085411T3 (it)
IE (1) IE914463A1 (it)
IT (1) IT1246050B (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100908068B1 (ko) * 2008-12-31 2009-07-15 주식회사 비케이티 대리석 석판, 대리석 석판 가공장치 및 그 가공방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione

Also Published As

Publication number Publication date
IT9022513A1 (it) 1992-06-21
CA2058228A1 (en) 1992-06-22
EP0492383A1 (en) 1992-07-01
ES2085411T3 (es) 1996-06-01
JPH04308529A (ja) 1992-10-30
DE69118847T2 (de) 1996-09-05
EP0492383B1 (en) 1996-04-17
ATE136776T1 (de) 1996-05-15
IT1246050B (it) 1994-11-07
KR920011482A (ko) 1992-07-24
DE69118847D1 (de) 1996-05-23
IE914463A1 (en) 1992-07-01

Similar Documents

Publication Publication Date Title
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
IT8941653A0 (it) Dispositivo per la correzione delle anomalie di rifrazione dell'occhio.
EP0331620A3 (en) Agent for the treatment of parkinson's disease
FI953915A0 (fi) Dupuytrenin taudin lievittämiseen
ITMI911096A0 (it) Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus
ITMI913465A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fuoroetano
IT1170238B (it) Impiego di ibuprofene e flurbiprofene nella cura dell'erpete
IT9022513A0 (it) Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.
IT1189308B (it) L'impiego in terapeutica d'un derivato dell'acetammide
ITMI912224A1 (it) Impiego di composti adenosinici nel trattamento dell'ischemia
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
ITMI931371A0 (it) Procedimento per la preparazione dell'erdosteina
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT8322370A0 (it) Applicazione terapeutica delmazindolo nella malattia di parkinson.
IT8819879A0 (it) Composizioni farmaceutiche atte all'impiego nella terapia dell'ipotensione arteriosa.
IT8822378A0 (it) Dispositivo per l'espletamento di necessita' fisiologiche per persone di sesso femminile.
IT1228176B (it) Stampo per la colata di getti nonche' suo impiego.
ITTO910676A0 (it) Perfezionamenti nella calcinazione dell'allumina.
IT214301Z2 (it) Perfezionamenti nella costruzione di fotopolimerizzatori
ITFI910140U1 (it) Presidio dell'articolazione scapolo-omerale
ITMI910966V0 (it) Regolo per l'indicazione dell'intensita' del dolore
MX9203508A (es) 1,7-difenil-3-metilaza -7-ciano-8-metilnonano para usarse en el tratamiento de enfermedades.
ES1012015Y (es) Calzado infantil perfeccionado.
IT8667196A1 (it) Perfezionamenti nella ribaltabilita' dell'appoggiatesta automobilistico.
IT9033302V0 (it) Trasferimento dell'appoggio nell'esercizio per le estremita'.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961230